metabolic Flashcards
if you have low blood glucose and hepatomegaly, what type of metabolic disorder should you be thinking of
Glycogen storage disease
what are the 4 types of glycogen storage disease
1) Affect liver and influence blood sugar (I VI, VIII)
2) involve muscles and affect ability to do anaerobic work (V, VIII)
3) Affect liver and muscles and influence B.G. and muscle metabolism (III)
4) Affect various tissues but have no direct effect on blood glucose or on the ability to do anaerobic work (II and IV)
How do you diagnose type I or type III Glycogen storage disease
Remember Type I - effects liver and influences blood sugar
Type III - affects liver and muscles and influences B.G and muscle metabolism
increased Serum uric acid
increased Serum lactate
increased Serum triglycerides
confirmed by DNA testing
if inconclusive - enzyme measurements in tissue from affected organ to confirm dx
Treatment of type I or type III Glycogen storage disease
maintain Blood glucose or supply alternate energy sources to the muscle
In type I (glucose-6-phosphatase deficiency) usually requires nocturnal intragastric feedings of glucose during the first 1-2 yrs of life then usually snacks and uncooked cornstarch may be satisfactory.
There is no specific treatment for the diseases of muscle that impair skeletal muscle ischemic exercise
Hepatic tumors (sometimes malignant) are a threat in adolescence and adult life for this glycogen storage disease
Type I and III
treatment of Type II Glycogen storage disease (Pompe disease)
Enzyme replacement early in life is effective - This disease also includes cardiac and skeletal muscle
deficiency of galactose-1-phosphate uridyltransferase
Galactosemia
what type of genetic disease is Galactosemia
Autosomal recessive
symptoms of Galactosemia
most striking in the neonate when fed milk, exhibits evidence of
Liver failure - hyperbilirubinemia, coag disorders, hypoglycemia
renal tubular function - acidosis, glycosuria, aminoaciduria
cateracts
Galactosemia is on the neonatal newborn screen so why is it still a problem
affected infants may die in the first week of life so you may not get the results fast enough
Affected infants with Galactosemia are at increased risk for
severe neonatal E.Coli sepsis
Impact of Galactosemia on infants, first few years of life, older children and girls
infants may die the first week of life
major effects on liver and kidney function and development of cataracts for first few years of life
older children may have learning disorders despite dietary compliance
Girls may develop premature ovarian failure despite treatment
Newborn screen
confirmed by lab manifestations
when galactose is ingested as lactose, levels of plasma glucose and erythrocyte galactose-1-phosphate are elevated
frequently hypoglycemic and have albuminuria
Galactose frequently present in urine
The diagnosis is made by showing extreme reduction in erythrocyte galactose-1-phosphate uridyltranferase activity
Diagnosis galactosemia
Treatment for galactosemia
elimination of dietary galactose results in rapid correction of abnormalities, but infants who are extremely ill before treatment may die before therapy is effective
most striking in the neonate when fed milk, exhibits evidence of
Liver failure - hyperbilirubinemia, coag disorders, hypoglycemia
renal tubular function - acidosis, glycosuria, aminoaciduria
cateracts
Galactosemia
symptoms of Galactokinase deficiency
what is the problem
cataract formation - if they are homozygous they usually develop cataracts after the neonatal period. If they are heterozygous, they are at risk as adults
ICP (rare)
problem is accumulation of galactose in body
symptoms of Hereditary fructose intolerance
what is the deficiency
what is it similar to
TX?
emesis hypoglycemia severe liver disease severe kidney disease fructosuria
fructose-1-phosphate aldolase
similar to Galactosemia
eliminate fructose and sucrose from diet prevents clinical disease
what grouping do these disorders fall under?
Glycogen storage diseases
Galactosemia
Galactokinase deficiency
Hereditary fructose intolerance
Carbohydrate Disorders